Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-Like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors

Cancer Cell - United States
doi 10.1016/j.ccell.2018.02.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability

Cancer Discovery
Oncology
2017English

KDM6A Loss Induces Aggressive Pancreatic Cancer in Mice

Cancer Discovery
Oncology
2018English

BRD4 Amplification Facilitates an Oncogenic Gene Expression Program in High-Grade Serous Ovarian Cancer and Confers Sensitivity to BET Inhibitors

PLoS ONE
Multidisciplinary
2018English

Phf8 Loss Confers Resistance to Depression-Like and Anxiety-Like Behaviors in Mice

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Loss of KDM6A Characterizes a Poor Prognostic Subtype of Human Pancreatic Cancer and Potentiates HDAC Inhibitor Lethality

International Journal of Cancer
Cancer ResearchOncology
2018English

Mutational Activation of BRAF Confers Sensitivity to Transforming Growth Factor Beta Inhibitors in Human Cancer Cells

Oncotarget
Oncology
2016English

Cancer Cells Acquire Super-Enhancers at Driver Genes

Cancer Discovery
Oncology
2013English

SMARCA2-deficiency Confers Sensitivity to Targeted Inhibition of SMARCA4 in Esophageal Squamous Cell Carcinoma Cell Lines

Scientific Reports
Multidisciplinary
2019English

Weight Loss Precedes Cancer-Specific Symptoms in Pancreatic Cancer-Associated Diabetes Mellitus

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy